Largo, FLNCT07755410Now EnrollingIRB Ready

Attention Deficit Disorder With Hyperactivity (ADHD) Clinical Trial in Largo, FL

Access cutting-edge attention deficit disorder with hyperactivity (adhd) treatment through this phase 2 clinical trial at a research site in Largo. Study-provided care at no cost to qualified participants.

Sponsored by Alkermes, Inc.

Quick Self-Assessment

See if you qualify for this Largo location

Preparing your pre-screening questions…

Expert Care in Largo

Access attention deficit disorder with hyperactivity (adhd) specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related attention deficit disorder with hyperactivity (adhd) treatment provided free

Apply for This Largo Location

Check if you qualify for this attention deficit disorder with hyperactivity (adhd) clinical trial in Largo, FL

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Largo

    Convenient for FL residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Largo site if eligible
  4. 4Begin participation

About This Attention Deficit Disorder With Hyperactivity (ADHD) Study in Largo

The purpose of this study is to measure safety and the improvement in symptoms in subjects with ADHD when taking ALKS 7290 tablets compared with placebo tablets.

Sponsor: Alkermes, Inc.

Who Can Participate

Inclusion Criteria

Meets the Diagnostic and Statistical Manual of Mental Disorders -5 criteria for ADHD, as confirmed by the Mini-International Neuropsychiatric Interview (MINI) for ADHD Studies 7.0.2.
Is otherwise healthy as determined by medical evaluation, including medical history, physical examination, laboratory tests, and cardiac monitoring. Participants must be stable on permitted medication for 2 months prior to first visit, without anticipated changes to dose.
AISRS total score of ≥26
CGI-S score ≥ 4 (moderately ill or worse)
Has a Body Mass Index within 18 to 35 kg/m2

Exclusion Criteria

Has a known history of intellectual developmental disorder or cognitive impairment that, in the opinion of the Investigator, would interfere with study participation.
Has any of the following psychiatric conditions per the DSM-5 criteria, as assessed by the MINI. Conditions not assessable by the MINI should be assessed by clinical judgement; Diagnosis of schizophrenia, schizoaffective disorder, or bipolar I or II disorder, or current, unstable, MDD or GAD.
Clinically significant cognitive difficulties including dementia, delirium or amnestic syndromes, or any other cognitive disorder present with the past 2 years that could interfere with participation in the study.
Moderate to severe substance use disorder according to DSM-5 guidelines, including use of alcohol, nicotine, cannabis, narcotics, or any illicit substance.
Any other psychiatric condition that could interfere with participation in the study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Largo?

Yes, this clinical trial (NCT07755410) has an active research site in Largo, FL that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Attention Deficit Disorder With Hyperactivity (ADHD) Treatment Options in Largo, FL

If you're searching for attention deficit disorder with hyperactivity (adhd) treatment options in Largo, FL, this clinical trial (NCT07755410) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Largo research site is actively enrolling participants for this phase 2 clinical trial. You'll receive care from experienced attention deficit disorder with hyperactivity (adhd) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all attention deficit disorder with hyperactivity (adhd) clinical trials near you to find additional studies recruiting in your area.

More Pulmonary Embolism Trials in Largo, FL

See all pulmonary embolism clinical trials recruiting in Largo — not just this study.

Browse Pulmonary Embolism Trials in Largo →

Browse More Trials by Condition

Pulmonary Embolism TrialsAlzheimers Disease TrialsHuntingtons Disease TrialsADHD TrialsRheumatoid Arthritis TrialsAtopic Dermatitis TrialsInterstitial Cystitis TrialsAll Conditions →

Ready to Join in Largo?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Largo, FL